Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs. Atorvastatin in African Americans with hypercholesterolemia
NCT00653744Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2002
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin in hypercholesterolemia, dyslipidemia, sponsored by AstraZeneca. Started Mar 2002; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on NCT00653744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653744.